Axsome Therapeutics (AXSM) Free Cash Flow (2015 - 2026)
Axsome Therapeutics recorded quarterly Free Cash Flow of -$20.8 million in Q1 2026, down 11.2% quarter-over-quarter from -$18.7 million in Q4 2025, and up 52.37% year-over-year from -$13.7 million in Q1 2025.
Axsome Therapeutics' Free Cash Flow history runs 12 years deep, the most recent figure standing at -$20.8 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 52.37% year-over-year to -$20.8 million; the TTM figure through Mar 2026 stood at -$71.0 million (up 40.26% YoY), while the FY2025 annual figure was -$93.9 million, up 27.04% from the prior year.
- Free Cash Flow came in at -$20.8 million for Q1 2026 at Axsome Therapeutics, down from -$18.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $988000.0 in Q3 2025 to a low of -$55.5 million in Q2 2023.
- A 5-year average of -$29.8 million and a median of -$30.2 million in 2024 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 809.11% in 2024 and soared 105.28% in 2025, its largest moves.
- Axsome Therapeutics' Free Cash Flow stood at -$27.7 million in 2022, then decreased by 9.46% to -$30.4 million in 2023, then advanced by 13.62% to -$26.2 million in 2024, then rose by 28.62% to -$18.7 million in 2025, then fell by 11.2% to -$20.8 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$20.8 million, -$18.7 million, and $988000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -20.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.82 Mn |
| Mar 31, 2026 | -20.82 Mn |
| Dec 31, 2025 | -18.72 Mn |
| Dec 31, 2025 | -18.72 Mn |
| Sep 30, 2025 | 988,000.00 |
| Sep 30, 2025 | 988,000.00 |
| Jun 30, 2025 | -32.44 Mn |
| Jun 30, 2025 | -32.44 Mn |
| Mar 31, 2025 | -43.71 Mn |
| Mar 31, 2025 | -43.71 Mn |
| Dec 31, 2024 | -26.23 Mn |
| Dec 31, 2024 | -26.23 Mn |
| Sep 30, 2024 | -18.72 Mn |
| Sep 30, 2024 | -18.72 Mn |
| Jun 30, 2024 | -30.16 Mn |
| Jun 30, 2024 | -30.16 Mn |
| Mar 31, 2024 | -53.57 Mn |
| Mar 31, 2024 | -53.57 Mn |
| Dec 31, 2023 | -30.37 Mn |
| Dec 31, 2023 | -30.37 Mn |
| Sep 30, 2023 | -53.92 Mn |
| Sep 30, 2023 | -53.92 Mn |
| Jun 30, 2023 | -55.48 Mn |
| Jun 30, 2023 | -55.48 Mn |
| Mar 31, 2023 | -5.89 Mn |
| Mar 31, 2023 | -5.89 Mn |
| Dec 31, 2022 | -27.74 Mn |
| Dec 31, 2022 | -27.74 Mn |
| Sep 30, 2022 | -22.82 Mn |
| Sep 30, 2022 | -22.82 Mn |
| Jun 30, 2022 | -33.78 Mn |
| Jun 30, 2022 | -33.78 Mn |
| Mar 31, 2022 | -32.87 Mn |
| Mar 31, 2022 | -32.87 Mn |
| Dec 31, 2021 | -28.84 Mn |
| Dec 31, 2021 | -28.84 Mn |
| Sep 30, 2021 | -27.03 Mn |
| Sep 30, 2021 | -27.03 Mn |
| Jun 30, 2021 | -25.41 Mn |
| Jun 30, 2021 | -25.41 Mn |
| Mar 31, 2021 | -27.25 Mn |
| Mar 31, 2021 | -27.25 Mn |
| Dec 31, 2020 | -20.57 Mn |
| Dec 31, 2020 | -20.57 Mn |
| Sep 30, 2020 | -15.75 Mn |
| Sep 30, 2020 | -15.75 Mn |
| Jun 30, 2020 | -18.90 Mn |
| Jun 30, 2020 | -18.90 Mn |
| Mar 31, 2020 | -23.28 Mn |
| Mar 31, 2020 | -23.28 Mn |
| Dec 31, 2019 | -17.57 Mn |
| Dec 31, 2019 | -17.57 Mn |
| Sep 30, 2019 | -10.63 Mn |
| Sep 30, 2019 | -10.63 Mn |
| Jun 30, 2019 | -8.68 Mn |
| Jun 30, 2019 | -8.68 Mn |
| Mar 31, 2019 | -9.50 Mn |
| Mar 31, 2019 | -9.50 Mn |
| Dec 31, 2018 | -9.79 Mn |
| Dec 31, 2018 | -9.79 Mn |
| Sep 30, 2018 | -5.92 Mn |
| Sep 30, 2018 | -5.92 Mn |
| Jun 30, 2018 | -7.68 Mn |
| Jun 30, 2018 | -7.68 Mn |
| Mar 31, 2018 | -6.70 Mn |
| Mar 31, 2018 | -6.70 Mn |
| Dec 31, 2017 | -6.29 Mn |
| Dec 31, 2017 | -6.29 Mn |
| Sep 30, 2017 | -6.45 Mn |
| Sep 30, 2017 | -6.45 Mn |
| Jun 30, 2017 | -7.10 Mn |
| Jun 30, 2017 | -7.10 Mn |
| Mar 31, 2017 | -6.64 Mn |
| Mar 31, 2017 | -6.64 Mn |
| Dec 31, 2016 | -7.22 Mn |
| Dec 31, 2016 | -7.22 Mn |
| Sep 30, 2016 | -4.88 Mn |
| Sep 30, 2016 | -4.88 Mn |
| Jun 30, 2016 | -5.33 Mn |
| Jun 30, 2016 | -5.33 Mn |
| Mar 31, 2016 | -3.96 Mn |
| Mar 31, 2016 | -3.96 Mn |
| Dec 31, 2015 | -2.25 Mn |
| Dec 31, 2015 | -2.25 Mn |
| Sep 30, 2015 | -1.93 Mn |
| Sep 30, 2015 | -1.93 Mn |
| Jun 30, 2015 | -2.11 Mn |
| Jun 30, 2015 | -2.11 Mn |
| Mar 31, 2015 | -1.17 Mn |
| Mar 31, 2015 | -1.17 Mn |